We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AGEP sine pustulosis induced by hydroxychloroquine used for COVID‐19 infection.
- Authors
Demircioğlu, Deniz; Karabıyık, Nilsun; Durmaz, Emel Öztürk; Demirkesen, Cüyan; Şahin, Sedef
- Abstract
AGEP sine pustulosis induced by hydroxychloroquine used for COVID-19 infection In the early phase of an eruption, when pustules are yet to appear clinically, it may be difficult, even impossible, to differentiate AGEP and skin rash of COVID-19 infection and a skin biopsy remains as the most valuable method in verifying the ultimate diagnosis. Hydroxychloroquine (HCQ) is an old drug with a new indication; it has recently been integrated into chemoprophylaxis and treatment protocols for severe acute respiratory 2 (SARS-CoV-2) infection.1 Acute generalized exanthematous pustulosis (AGEP) is by far, the most common serious dermatological side effect of HCQ.2 We have recently encountered an atypical case of AGEP triggered by HCQ in a patient treated for SARS-CoV-2 infection.
- Subjects
COVID-19; HYDROXYCHLOROQUINE; DRUG eruptions; COVID-19 pandemic; BUTTOCKS
- Publication
Dermatologic Therapy, 2022, Vol 35, Issue 3, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.15263